ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

New Approaches To Therapy For Difficult Cancers Presented

June 29, 2007

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

New Concept For Prevention Units Goes to DCPC BSC

April 24, 1987

BMS Award Honors Jordan; Matthews Media Wins $23 Million Contract From MCI.

April 6, 2001

Oncology Nursing Society Installs Officers, Offers Virtual Congress Online For Credit.

June 15, 2001

Moffitt, Ohio State Form Network, Invite Major Cancer Centers to Join

May 30, 2014